AAAAAA
Results:
1-21
|
Results: 21
Authors:
Baumhakel, M
Kasel, D
Rao-Schymanski, RA
Bocker, R
Beckurts, KT
Zaigler, M
Barthold, D
Fuhr, U
Citation: M. Baumhakel et al., Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes, INT J CL PH, 39(12), 2001, pp. 517-528
Authors:
Tantcheva-Poor, I
Servera-Llaneras, M
Scharffetter-Kochanek, K
Fuhr, U
Citation: I. Tantcheva-poor et al., Liver cytochrome P450CYP1A2 is markedly inhibited by systemic but not by bath PUVA in dermatological patients, BR J DERM, 144(6), 2001, pp. 1127-1132
Authors:
Iwuoha, EI
Kane, S
Ania, CO
Smyth, MR
de Montellano, PRO
Fuhr, U
Citation: Ei. Iwuoha et al., Reactivities of organic phase biosensors 3: Electrochemical study of cytochrome P450(cam) immobilized in a methyltriethoxysilane sol-gel, ELECTROANAL, 12(12), 2000, pp. 980-986
Authors:
Zaigler, M
Rietbrock, S
Szymanski, J
Dericks-Tan, JSE
Staib, AH
Fuhr, U
Citation: M. Zaigler et al., Variation of CYP1A2-dependent caffeine metabolism during menstrual cycle in healthy women, INT J CL PH, 38(5), 2000, pp. 235-244
Authors:
Fuhr, U
Citation: U. Fuhr, The 13th Symposium of the "Working Group for Pharmacology in Oncology and Hematology" - Overview of presentations, INT J CL PH, 38(3), 2000, pp. 141-142
Authors:
Wilde, S
Jetter, A
Menzel, H
Rietbrock, S
Zaigler, M
Sieber, M
Tesch, H
Hempel, G
Reif, S
Jaehde, U
Merkel, U
Johnson, S
Diehl, V
Fuhr, U
Citation: S. Wilde et al., Population pharmacokinetics of drugs in the BEACOPP chemotherapy regimen used in Hodgkin's disease, INT J CL PH, 38(3), 2000, pp. 147-149
Authors:
Kasel, D
Baumhakel, M
Fuhr, U
Citation: D. Kasel et al., Biodegradation of procarbazine by human liver microsomes, INT J CL PH, 38(3), 2000, pp. 153-155
Authors:
Zaigler, M
Tantcheva-Poor, I
Fuhr, U
Citation: M. Zaigler et al., Problems and perspectives of phenotyping for drug-metabolizing enzymes in man, INT J CL PH, 38(1), 2000, pp. 1-9
Authors:
Beckmann-Knopp, S
Rietbrock, S
Weyhenmeyer, R
Bocker, RH
Beckurts, KT
Lang, W
Hunz, M
Fuhr, U
Citation: S. Beckmann-knopp et al., Inhibitory effects of silibinin on cytochrome P-450 enzymes in human livermicrosomes, PHARM TOX, 86(6), 2000, pp. 250-256
Authors:
Fuhr, U
Citation: U. Fuhr, "Clinically relevant" new drug interactions, MED KLIN, 95, 2000, pp. 18-22
Authors:
Fuhr, U
Citation: U. Fuhr, Induction of drug metabolising enzymes - Pharmacokinetic and toxicologicalconsequences in humans, CLIN PHARMA, 38(6), 2000, pp. 493-504
Authors:
Rietbrock, S
Wissing, H
Kuhn, I
Fuhr, U
Citation: S. Rietbrock et al., Pharmacokinetics of inhaled anaesthetics in a clinical setting: description of a novel method based on routine monitoring data, BR J ANAEST, 84(4), 2000, pp. 437-442
Authors:
Wissing, H
Kuhn, I
Rietbrock, S
Fuhr, U
Citation: H. Wissing et al., Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparisonof desflurane, isoflurane and sevoflurane, BR J ANAEST, 84(4), 2000, pp. 443-449
Authors:
Tantcheva-Poor, I
Zaigler, M
Rietbrock, S
Fuhr, U
Citation: I. Tantcheva-poor et al., Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test (vol 9, pg 131, 1999), PHARMACOGEN, 9(6), 1999, pp. 781-781
Authors:
Tantcheva-Poor, I
Zaigler, M
Rietbrock, S
Fuhr, U
Citation: I. Tantcheva-poor et al., Estimation of cytochrome P-450CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test, PHARMACOGEN, 9(2), 1999, pp. 131-144
Authors:
Rost, KL
Fuhr, U
Thomsen, T
Zaigler, M
Brockmoller, J
Bohnemeier, H
Roots, I
Citation: Kl. Rost et al., Omeprazole weakly inhibits CYP1A2 activity in man, INT J CL PH, 37(11), 1999, pp. 567-574
Authors:
Beckmann-Knopp, S
Rietbrock, S
Weyhenmeyer, R
Bocker, RH
Beckurts, KT
Lang, W
Fuhr, U
Citation: S. Beckmann-knopp et al., Inhibitory effects of trospium chloride on cytochrome P450 enzymes in human liver microsomes, PHARM TOX, 85(6), 1999, pp. 299-304
Authors:
Fuhr, U
Citation: U. Fuhr, "Clinically relevant" new drug interactions, MED KLIN, 94(2), 1999, pp. 120-124
Authors:
Jakus, V
Fuhr, U
Worner, W
Rietbrock, N
Citation: V. Jakus et al., Erythrocyte membrane fluidity in diabetics: Fluorescence study, COLL CZECH, 64(3), 1999, pp. 548-552
Authors:
Kinzig-Schippers, M
Fuhr, U
Zaigler, M
Dammeyer, J
Rusing, G
Labedzki, A
Bulitta, J
Sorgel, F
Citation: M. Kinzig-schippers et al., Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2, CLIN PHARM, 65(3), 1999, pp. 262-274
Authors:
Iwuoha, EI
Joseph, S
Zhang, Z
Smyth, MR
Fuhr, U
de Montellano, PRO
Citation: Ei. Iwuoha et al., Drug metabolism biosensors: electrochemical reactivities of cytochrome P450(cam) immobilised in synthetic vesicular systems, J PHARM B, 17(6-7), 1998, pp. 1101-1110
Risultati:
1-21
|